Inovio Pharmaceuticals (INO)
NASDAQ:INO

Inovio Pharmaceuticals (INO) Stock Forecast & Price Target

5,462 Followers
See the Price Targets and Ratings of:

INO Analyst Ratings

Hold
4Ratings
0 Buy
3 Hold
1 Sell
Based on 4 analysts giving stock ratings to
Inovio
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

INO Stock 12 Months Forecast

Average Price Target

$2.50
▲(44.51% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Inovio Pharmaceuticals in the last 3 months. The average price target is $2.50 with a high forecast of $3.00 and a low forecast of $2.00. The average price target represents a 44.51% change from the last price of $1.73.
Highest Price Target$3.00Average Price Target$2.50Lowest Price Target$2.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Cantor Fitzgerald
$3.00
Buy
73.41%
Upside
Reiterated
Inovio price target lowered to $3 from $6 at Cantor FitzgeraldInovio price target lowered to $3 from $6 at Cantor Fitzgerald
Stifel Nicolaus
$1.00
Hold
-42.20%
Downside
Reiterated
Inovio Pharmaceuticals (INO) PT Lowered to $1 at StifelStifel analyst Stephen D. Willey lowered the price target on Inovio Pharmaceuticals (NASDAQ: INO) to $1.00 (from $3.00) while maintaining a Hold rating.
Oppenheimer
Hold
Downgraded
Inovio downgraded to Perform from Outperform at OppenheimerInovio downgraded to Perform from Outperform at Oppenheimer
Jefferies
$6.00
Hold
246.82%
Upside
Initiated
Inovio initiated with a Hold at JefferiesInovio initiated with a Hold at Jefferies
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

INO Financial Forecast

INO Earnings Forecast
Next quarter’s earnings estimate for INO is -$0.17 with a range of -$0.19 to -$0.14. The previous quarter’s EPS was -$0.15. INO beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.50% of the time in the same period. In the last calendar year INO has Underperformed its overall industry.
Next quarter’s earnings estimate for INO is -$0.17 with a range of -$0.19 to -$0.14. The previous quarter’s EPS was -$0.15. INO beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.50% of the time in the same period. In the last calendar year INO has Underperformed its overall industry.
INO Sales Forecast
Next quarter’s sales forecast for INO is $697.00K with a range of $0.00 to $2.50M. The previous quarter’s sales results were $9.15M. INO beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.84% of the time in the same period. In the last calendar year INO has Outperformed its overall industry.
Next quarter’s sales forecast for INO is $697.00K with a range of $0.00 to $2.50M. The previous quarter’s sales results were $9.15M. INO beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.84% of the time in the same period. In the last calendar year INO has Outperformed its overall industry.
INO Analyst Recommendation Trends
In the current month, INO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The INO average analyst price target in the past 3 months is $2.50
In the current month, INO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The INO average analyst price target in the past 3 months is $2.50

INO Stock Forecast FAQ

What is INO’s average 12-month price target, according to analysts?
Based on analyst ratings, Inovio Pharmaceuticals’s 12-month average price target is $2.50.
    What is INO’s upside potential, based on the analysts’ average price target?
    Inovio Pharmaceuticals has 44.51% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is INO a Buy, Sell or Hold?
          Inovio Pharmaceuticals has a conensus rating of Hold which is based on 0 buy ratings, 3 hold ratings and 1 sell ratings.
            What is Inovio Pharmaceuticals’s price target?
            The average price target for Inovio Pharmaceuticals is $2.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $3.00 ,the lowest forecast is $2.00. The average price target represents 44.51% Increase from the current price of $1.73.
              What do analysts say about Inovio Pharmaceuticals?
              Inovio Pharmaceuticals’s analyst rating consensus is a ‘Hold. This is based on the ratings of 4 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis